Stocks and Investing Stocks and Investing
Wed, November 16, 2022
Tue, November 15, 2022

Brian Abrahams Maintained (VRTX) at Hold and Held Target at $301 on, Nov 15th, 2022


Published on 2024-10-28 00:11:35 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold and Held Target at $301 on, Nov 15th, 2022.

Brian has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 4 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Skorney of "Baird" Maintained at Hold and Held Target at $280 on, Monday, October 31st, 2022
  • Paul Matteis of "Stifel" Maintained at Hold and Held Target at $289 on, Sunday, October 30th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $285 on, Friday, October 28th, 2022
  • Do Kim of "Piper Sandler" Maintained at Hold with Increased Target to $288 on, Wednesday, August 17th, 2022


These are the ratings of the 9 analyists that currently disagree with Brian


  • Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $350 on, Friday, November 11th, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $442 on, Monday, October 31st, 2022
  • Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $330 on, Friday, October 28th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $313 on, Friday, October 28th, 2022
  • Michael Yee of "Jefferies" Maintained at Strong Buy and Held Target at $340 on, Friday, October 28th, 2022
  • Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $335 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $327 on, Monday, October 24th, 2022
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $337 on, Friday, October 21st, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $300 on, Friday, August 5th, 2022
Contributing Sources